CTAs keep buying Treasuries, gold longs face stop-loss risk: BofA
CD&R Investment Associates XII, Ltd., CD&R Channel Holdings II, L.P., and CD&R Associates XII, L.P., all entities related to Clayton, Dubilier & Rice, reported purchasing shares of Resideo Technologies Inc (NASDAQ:NYSE:REZI) between August 8 and August 12, 2025. The total value of these purchases amounted to $35,207,906, with prices ranging from $27.3003 to $31.4902.
The purchases were made in multiple transactions. On August 8, 448,887 shares were bought at a weighted average price of $27.3003, in a range from $27.08 to $27.67. On August 11, 457,508 shares were acquired at an average price of $27.3366, with prices varying from $27.10 to $27.67. These transactions occurred as the stock approached its 52-week high of $31.59.
The purchases continued on August 12, with 91,417 shares bought at an average price of $30.0345, in a price range between $29.42 and $30.415. An additional 216,432 shares were purchased at an average price of $30.9423, with prices ranging from $30.42 to $31.41. The final purchase on August 12 involved 31,879 shares at an average price of $31.4902, with prices between $31.42 and $31.585.
Following these transactions, the entities now directly own 11,478,543 shares of Resideo Technologies, Inc., representing a significant position in the company, which currently has a market capitalization of $4.65 billion. InvestingPro analysis indicates the stock is trading near its Fair Value, with analysts projecting profitability for the current year. Get access to 12 more exclusive InvestingPro Tips and comprehensive analysis through the Pro Research Report.
In other recent news, Resideo Technologies reported strong financial results for the second quarter of 2025, surpassing both earnings and revenue forecasts. The company achieved an earnings per share of $0.66, exceeding the expected $0.54, which represents a 22.22% surprise. Revenue for the quarter reached $1.94 billion, above the anticipated $1.83 billion. Additionally, Morgan Stanley (NYSE:MS) upgraded Resideo Technologies from Equalweight to Overweight, highlighting the company’s earnings potential. The firm also raised its price target to $35.00 from $24.00, indicating a potential 27% upside. This upgrade follows Resideo’s strongest quarter of organic revenue growth in 15 quarters and nine consecutive quarters of gross margin expansion in its Products & Solutions segment. These developments reflect positive momentum for Resideo Technologies in the current market landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.